Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally?
West Pharmaceutical Services (WST) stock, currently priced at US$300.68, shows mixed returns but a strong 42.8% gain over the last year. However, valu...
West Pharmaceutical Services (WST) stock, currently priced at US$300.68, shows mixed returns but a strong 42.8% gain over the last year. However, valu...
Bullish
West Pharmaceutical Services Inc. reported strong first-quarter 2026 results with net sales up 21.0% to $844.9 million and diluted earnings per share ...
West Pharmaceutical Services exceeded Wall Street's expectations in Q1, driven by strong demand for high-value product (HVP) components and operationa...
Bullish
HB Wealth Management LLC reduced its stake in West Pharmaceutical Services (NYSE: WST) by 27.3% in the fourth quarter, selling 3,325 shares but still ...
West Pharmaceutical Services, Inc. reported strong first-quarter 2026 results, with EPS of $2.13 exceeding estimates by $0.45 and revenue of $844.90 m...
West Pharmaceutical Services (WST) has seen significant short-term share price momentum, gaining nearly 24% over the last month, yet its longer-term p...
West Pharmaceutical Services (WST) exceeded Q1 CY2026 revenue and profit expectations, driven by strong demand for high-value product (HVP) components...
West Pharmaceutical Services (WST) experienced a decline in its net profit margin to 16.1% in Q4 2025, down from 17% a year prior, despite quarterly r...
Neutral
West Pharmaceutical Services (WST) is set to report its Q1 earnings this Thursday morning. Analysts expect the company's revenue to grow 11.6% year-on...
West Pharmaceutical Services is gaining renewed investor attention due to its central role in the expanding global wearable injectors market, driven b...
Bullish
West Pharmaceutical, a leader in injectable drug packaging, is well-positioned for growth due to increasing demand for biologics and vaccines. The com...
Neutral
Local Pensions Partnership Investment Ltd lessened its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.4% in th...
Neutral
Annex Advisory Services LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 8.7% during the 4th quarter, ...